The new Category III code, CPT 1019T Lymphovenous bypass, including robotic assistance, when performed, per extremity, will become effective in the U.S. on January 1, 2026.

When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for ...

Medical offices bill insurance providers for clients' services. Learn what's involved, including HIPAA regulations, what to include and what can go wrong.

The healthcare industry is no stranger to technological advancements, and artificial intelligence (AI) is quickly becoming a game-changer in multiple areas. From diagnosing medical conditions to ...

Recent survey and system data are again suggesting that payers’ increasing claims denials are a pain point for healthcare providers. Nearly three-quarters of the 210 provider revenue cycle leaders ...

Helius Medical Technologies, Inc. has announced that Aetna Healthcare has authorized payment for the PoNS Device at an out-of-network negotiated price of $18,350, making Aetna the third major payer to ...